Clinical Trials Sponsored by Aria Aesthetics Inc.

Total 88 results

Aria Aesthetics Inc.

Completed

The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage

Rosacea | Acne Vulgaris | Seborrheic Dermatitis | Atopic Dermatitis

United States
Revelle Aesthetics, Inc

Completed

CONtrolled Focal Fibrous Band Release Method Study (CONFFIRM)

Cellulite

United States, Australia
Medicis Aesthetics, Inc.

Completed

A Study to Determine How Long Restylane® Will Last After Initial Treatment With 2 Different Re-treatment Schedules.

Rhytids

United States
Silk Medical Aesthetics, Inc.

Completed

Histology of SMA-001 in the Abdomen

Abdominoplasty | Medical Aesthetics

United States
Neothetics, Inc

Completed

Pilot Study to Determine Safety and Efficacy of Orbital Injections of LIPO-102 in Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease (TED)

Thyroid-Related Eye Disease

Australia, New Zealand
Neothetics, Inc

Completed

Dose Ranging Study (RESET)

Periumbilical Subcutaneous Adipose Tissue Reduction

United States
Neothetics, Inc

Completed

Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat

Submental Fat

United States
Neothetics, Inc

Unknown

An Open-Label Study to Evaluate Retreatment With LIPO-202

Central Abdominal Bulging

United States
Neothetics, Inc

Completed

An Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity

Subcutaneous Abdominal Adiposity

United States
Neothetics, Inc

Completed

A Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo for the Reduction of Abdominal Subcutaneous Adiposity

Weight

United States
Neothetics, Inc

Completed

Dose-ranging Study (LIPO-102-CL-11)

Abdominal Contour Defects

United States
Neothetics, Inc

Completed

Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR1)

Central Abdominal Bulging

United States
Neothetics, Inc

Completed

Safety and Efficacy Study of LIPO-202 for the Reduction of Central Abdominal Bulging in Obese Subjects

Central Abdominal Bulging

United States
Neothetics, Inc

Completed

An Evaluation of the Pharmacokinetics and Safety of LIPO-102 in Healthy Volunteers

Subcutaneous Adipose Tissue Reduction

United States
Neothetics, Inc

Completed

Dose Ranging and Dose Frequency of LIPO-102

Subcutaneous Adipose Tissue Reduction

United States
DeNova Research
Merz Aesthetics Inc.

Completed

Injectable Filler for Cheek Flattening

Malar Deficiency

United States
Evofem Inc.
Neothetics, Inc

Terminated

Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202

Central Abdominal Bulging
Evofem Inc.
Neothetics, Inc

Completed

Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)

Central Abdominal Bulging

United States
Dominion Aesthetic Technologies, Inc.

Completed

Eon™ FR 1064 Full Abdomen Clinical Study Protocol

Abdominal Obesity

United States
Dominion Aesthetic Technologies, Inc.

Completed

Eon® Flanks Safety Clinical Study Protocol

Adipose Tissue

United States
Advanced Aesthetic Technologies, Inc

Recruiting

Algeness DF 3.5% Compared to Voluma in Volume Deficit in Mid-face

Age-Related Volume Deficit in the Mid-Face

Belgium, France, Germany, Israel, Malaysia, Spain, United Arab Emirates
Dominion Aesthetic Technologies, Inc.

Completed

Eon™ FR Clinical Study Protocol 1064

Fat Disorder

United States
Aria CV, Inc

Recruiting

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System (ASPIRE PH)

Pulmonary Arterial Hypertension | Pulmonary Hypertension | Right Heart Dysfunction

United States
Aria CV, Inc

Completed

Acute Assessment of the Aria CV System in Patients With WHO Groups 2 and 3 Pulmonary Hypertension

Pulmonary Hypertension

Austria
Merz North America, Inc.
Merz Aesthetics Inc.

Completed

Evaluation of Radiesse® Dermal Filler for Hand Treatment

Aging Hands

United States
Merz Aesthetics GmbH

Completed

A Study of NT 201 Doses in the Treatment of Platysma Prominence (PAOLA)

Platysma Prominence

United States
Zel Skin and Laser Specialists
Merz Aesthetics Inc.

Active, not recruiting

Use of Botulinum Toxin in the Treatment of Androgenic Alopecia

Androgenetic Alopecia

United States
ARCA Biopharma, Inc.

Completed

Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters

Thrombosis | Venous Thrombosis | Catheter Occlusion

United States
ARCA Biopharma, Inc.

Completed

Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters

Thrombosis | Venous Thrombosis

United States
ARCA Biopharma, Inc.

Unknown

Study of NU172 as Anticoagulation in Patients Undergoing Off-pump CABG Surgery (SNAP-CABG-OFF)

Heart Disease
ARCA Biopharma, Inc.

Terminated

Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery

Arterial Occlusive Diseases

United States
ARCA Biopharma, Inc.

Completed

Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices

Catheters, Indwelling

United States
ARCA Biopharma, Inc.

Suspended

Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer

Colon Cancer

United States
ARCA Biopharma, Inc.

Terminated

Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke

Acute Ischemic Stroke

United States, Canada
ARCA Biopharma, Inc.

Completed

Study of Alfimeprase to Rapidly Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery on Leg Arteries

Arterial Occlusive Diseases

United States
Merz Aesthetics GmbH
Merz Pharmaceuticals GmbH

Completed

Investigation of the Effectiveness and Safety of MRZF111 in the Treatment of Décolleté Wrinkles

Décolleté Wrinkles

Germany
Merz Aesthetics GmbH
Merz Pharmaceuticals GmbH

Completed

Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines

Moderate to Severe Glabellar Frown Lines

United States, Germany
ARCA Biopharma, Inc.
Medtronic

Completed

Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure (GENETIC-AF)

Current or Recent History of Atrial Fibrillation

United States, Canada, Hungary, Netherlands, Poland, Serbia
United Biomedical Inc., Asia

Withdrawn

A Study to Evaluate the Ability of UB-612 COVID-19 Vaccine to Boost Immunity of Heterologous COVID-19 Vaccines.

COVID-19
United Biomedical Inc., Asia
Vaxxinity, Inc.

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine

COVID-19

Taiwan
Skin Care and Laser Physicians of Beverly Hills
Merz Aesthetics Inc.

Unknown

A Study Evaluating Blended Belotero for the Treatment of Etched-in Fine Facial Lines

Rhytidosis Facialis

United States
United Biomedical Inc., Asia
Vaxxinity, Inc.

Terminated

A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers

COVID-19

Taiwan
United Biomedical Inc., Asia
Vaxxinity, Inc.

Completed

A Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine

COVID-19

Taiwan
Lupo Center for Aesthetic and General Dermatology
Evolus, Inc.

Completed

Spread of PrabotulinumtoxinA-xvfs Versus OnabotulinumtoxinA in the Treatment of Forehead Rhytides

Rhytides

United States
ARCA Biopharma, Inc.
Health Decisions

Completed

Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion

Arterial Occlusive Diseases | Thrombosis | Peripheral Vascular Diseases

United States
McDaniel Institute of Anti-Aging Research
Allergan; Merz Aesthetics Inc.; ThermiGen, LLC

Unknown

Facial Asymmetrical Clinical Evaluation Study (FACE)

Loss of Facial Adipose Tissue

United States
ARNA Genomics US Inc.
BIOMARKER-RU

Recruiting

Retrospective Comparative in Vitro Case-controlled Study of the Liquid Biopsy Test System in Women With Breast Cancer

Breast Neoplasm Female

Russian Federation
ARNA Genomics US Inc.
BIOMARKER-RU

Not yet recruiting

In Vitro Study of the Liquid Biopsy Test System of the Diagnostic Value, in Women With Various Forms of Breast Cancer (ARNABreast)

Breast Neoplasms
ARCA Biopharma, Inc.
Colorado Prevention Center

Completed

Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19 (ASPEN)

Covid19

United States, Argentina, Brazil
Bay Area Retina Associates
QLT Inc.

Completed

Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration (PDEX)

Age Related Macular Degeneration

United States

3

Subscribe